| 1 |
27045516 | The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation. | 2016 |
5 |
| 2 |
27793909 | Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs. | 2016 Nov |
1 |
| 3 |
24874696 | Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy. | 2014 Oct |
1 |
| 4 |
24284282 | Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition. | 2013 Nov 22 |
1 |
| 5 |
21302473 | [Polymorphism at the MDR1 locus as a cause of mefloquine-induced psychosis]. | 2010 Sep |
2 |
| 6 |
16843615 | Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. | 2006 |
1 |
| 7 |
17015054 | MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. | 2006 Oct |
6 |
| 8 |
11683248 | The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase. | 2001 Sep |
2 |
| 9 |
11031728 | Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. | 2000 Jun |
3 |
| 10 |
8937469 | Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. | 1996 Nov 22 |
6 |